Susan Blum
Patrimonio netto: 957 226 $ in data 30/09/2026
Patrimonio netto: 957 226 $ in data 30/09/2026
Susan Blum is Chief Financial Officer & Executive Vice President at CorMedix, Inc. since 2025.
Formerly, Ms. Blum was Independent Director at BiomX, Inc. from 2024 to 2026, Chief Financial Officer at Melinta Therapeutics, Inc. from 2021 to 2025, and Controller at Textura Corp.
from 2013 to 2016.
Ms. Blum completed undergraduate education at Santa Clara University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CORMEDIX INC. 0,16% | 29/08/2026 | 124.315 ( 0,16% ) | 957 226 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CORMEDIX INC. | Direttore Finanziario/CFO | 29/08/2025 |
| Società | Posizione | Fine |
|---|---|---|
| TESSERA DEFENSE AND HOMELAND SECURITY INC. | Direttore/Membro del Consiglio | 24/02/2026 |
| MELINTA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 29/08/2025 |
| TEXTURA CORP | Comptroller/Controller/Auditor | 01/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
CorMedix, Inc.
CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Textura Corp.
Textura Corp. Packaged SoftwareTechnology Services Develops software for real estate developers and contractors construction projects | Technology Services |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
BiomX, Inc.
BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale